Breathe Well Live Well
The Pharmaceutical Journal |
Very poorly controlled asthma lasts more than a decade for half of patients
The Pharmaceutical Journal The researchers, who presented their results at the American Thoracic Society International Conference on 15–18 May 2016, say that alternative treatment strategies and helping patients to quit smoking could improve the asthma control of these patients. |
View full post on asthma – Google News
|
Very poorly controlled asthma may persist for more than a decade despite treatment
Healio Almost half of patients with severe or difficult-to-treat asthma in the TENOR II cohort still had symptoms of very poorly controlled asthma following more than a decade of treatment, according to data presented at the annual American Thoracic Society … |
View full post on asthma – Google News
|
Very poorly controlled asthma highly prevalent in TENOR II cohort after more than a decade
EurekAlert (press release) ATS 2016, SAN FRANCISCO — Nearly half (48%) of patients with severe or difficult-to-treat asthma in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens follow-up study (TENOR II) still had very poorly controlled (VPC) … |
View full post on asthma – Google News
|
Child Asthma Cases Are Declining Following Two Decade Spike
WOAI.com A federal study out this morning shows that after spiking for the past decade, rates of childhood asthma are leveling off or even declining, News Radio 1200 WOAI's Michael Board reports. The study by the National Center for Health Statistics say the … |
View full post on asthma – Google News
AsiaOne |
Asthma on the rise in China over past decade
AsiaOne Asthma cases have risen dramatically in China over the past decade along with ever deteriorating air pollution, according to leading respiratory specialists. Nationwide, the prevalence of asthma stands at 1 to 2 per cent, while in some cities it can … |
View full post on asthma – Google News
|
Report: Asthma market to remain stable during next decade
Healio The asthma market is projected to remain stable in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan with a slight increase from $15.1 billion in 2013 to $16.1 billion in 2023, according to a report from Decision Resources … Asthma market to remain stable over next decade, despite generic erosion |
View full post on asthma – Google News
The Pharma Letter |
Asthma market to remain stable over next decade, despite generic erosion
The Pharma Letter New market potential in underserved asthma population: Emerging anticytokines that are predicted to launch during the next decade will serve part of the unmet need in the severe, refractory asthma population, which is currently served by only systemic … |
View full post on asthma – Google News
|
The Asthma Market Is Forecast to Remain Stable over the Next Decade, Despite …
The Providence Journal BURLINGTON, Mass., Oct. 8, 2014 /PRNewswire/ — Decision Resources Group finds that the market for asthma will remain stable, increasing slightly from $15.1 billion in 2013 to $16.1 billion in 2023 in the United States, France, Germany, Italy, Spain … |
View full post on asthma – Google News
|
The Asthma Market Is Forecast to Remain Stable over the Next Decade, Despite …
MarketWatch BURLINGTON, Mass., Oct. 8, 2014 /PRNewswire/ — Decision Resources Group finds that the market for asthma will remain stable, increasing slightly from $15.1 billion in 2013 to $16.1 billion in 2023 in the United States, France, Germany, Italy, Spain … |
View full post on asthma – Google News
Arab News |
Asthma cases increased by 300% in last decade
Arab News He said it is reported that the number of asthma cases in the last decade have increased by 300 percent. The main objective of the establishing of events is to increase awareness of the disease, especially in this society, where an estimated 1.5 … |
View full post on asthma – Google News